Chat with this insight
Save time and jump to the most important pieces.
Recent Analyst Ratings for $CLB
Date | Price Target | Rating | Analyst |
---|---|---|---|
3/12/2025 | $15.00 → $16.00 | Sell → Neutral | Citigroup |
6/30/2023 | $22.00 → $21.00 | Neutral → Sell | Citigroup |
4/18/2023 | $21.50 | Neutral → Underperform | BofA Securities |
1/9/2023 | Underperform → Neutral | BofA Securities | |
10/7/2022 | $24.00 → $17.00 | Sell → Neutral | Citigroup |
9/26/2022 | $20.00 | Equal-Weight → Underweight | Morgan Stanley |
4/18/2022 | $19.50 → $21.30 | Neutral → Underweight | Piper Sandler |
1/18/2022 | $32.00 → $30.00 | Equal-Weight | Morgan Stanley |
CORE LABORATORIES ANNOUNCES TIMING OF FIRST QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL
HOUSTON, March 24, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its first quarter 2025 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m. EST on April 24, 2025. Larry Bruno, Chairman and CEO, Chris Hill, CFO, and Gwen Gresham, SVP Corporate Development and Investor Relations, will discuss financial and operational results. An earnings press release will be issued after market close on April 23, 2025, and may be accessed through the Company's website at www.corelab.com. To register for the listen-only webcast, log on to www.corelab.com at least fifteen minutes prior to the start of the call. For those not available to listen to the live webcast, a replay
CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS
FOURTH QUARTER REVENUE OF $129.2 MILLION, DOWN 4% SEQUENTIALLY AND UP SLIGHTLY YEAR-OVER-YEARFOURTH QUARTER OPERATING INCOME OF $14.2 MILLION; EX-ITEMS, $15.7 MILLION, DOWN 14% SEQUENTIALLY, UP 4% YEAR-OVER-YEAR FOURTH QUARTER OPERATING MARGINS, EX-ITEMS, OF 12% FOURTH QUARTER GAAP EPS OF $0.15; EX-ITEMS, $0.22, DOWN 12% SEQUENTIALLY, UP 16% YEAR-OVER-YEAR FOURTH QUARTER FREE CASH FLOW OF $16.2 MILLION, UP OVER 50% SEQUENTIALLY DEBT LEVERAGE RATIO REDUCED TO 1.31, AND NET DEBT REDUCED BY $11.7 MILLION COMPANY REPURCHASED 264,982 SHARES OF COMMON STOCK, A VALUE OF $4.9 MILLION, DURING THE FOURTH QUARTER COMPANY ANNOUNCES Q1 2025 QUARTERLY DIVIDENDFULL YEAR REVENUE OF $523.8 MILLION, UP 3%FULL
CORE LABORATORIES ANNOUNCES TIMING OF FOURTH QUARTER 2024 EARNINGS RELEASE AND CONFERENCE CALL
HOUSTON, Jan. 3, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its fourth quarter 2024 conference call for investors and analysts at 7:30 a.m. CST / 8:30 a.m. EST on January 30, 2025. Larry Bruno, Chairman and CEO, Chris Hill, CFO, and Gwen Gresham, SVP Corporate Development and Investor Relations, will discuss financial and operational results. An earnings press release will be issued after market close on January 29, 2025 and may be accessed through the Company's website at www.corelab.com. To register for the listen-only webcast, log on to www.corelab.com at least fifteen minutes prior to the start of the call. For those not available to listen to the live webcast, a
Core Labs upgraded by Citigroup with a new price target
Citigroup upgraded Core Labs from Sell to Neutral and set a new price target of $16.00 from $15.00 previously
Core Labs downgraded by Citigroup with a new price target
Citigroup downgraded Core Labs from Neutral to Sell and set a new price target of $21.00 from $22.00 previously
Core Labs downgraded by BofA Securities with a new price target
BofA Securities downgraded Core Labs from Neutral to Underperform and set a new price target of $21.50
SEC Form 4 filed by CAO & Treasurer Teo Sow Hang
4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
SEC Form 4 filed by SVP, Gen Counsel & Secretary Tattoli Mark Damian
4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
SEC Form 4 filed by SVP Gresham Gwendolyn
4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
SEC Form DEFA14A filed by Core Laboratories Inc.
DEFA14A - Core Laboratories Inc. /DE/ (0001958086) (Filer)
SEC Form DEF 14A filed by Core Laboratories Inc.
DEF 14A - Core Laboratories Inc. /DE/ (0001958086) (Filer)
Amendment: SEC Form SCHEDULE 13G/A filed by Core Laboratories Inc.
SCHEDULE 13G/A - Core Laboratories Inc. /DE/ (0001958086) (Subject)
CORE LABORATORIES ANNOUNCES TIMING OF FIRST QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL
HOUSTON, March 24, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its first quarter 2025 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m. EST on April 24, 2025. Larry Bruno, Chairman and CEO, Chris Hill, CFO, and Gwen Gresham, SVP Corporate Development and Investor Relations, will discuss financial and operational results. An earnings press release will be issued after market close on April 23, 2025, and may be accessed through the Company's website at www.corelab.com. To register for the listen-only webcast, log on to www.corelab.com at least fifteen minutes prior to the start of the call. For those not available to listen to the live webcast, a replay
CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS
FOURTH QUARTER REVENUE OF $129.2 MILLION, DOWN 4% SEQUENTIALLY AND UP SLIGHTLY YEAR-OVER-YEARFOURTH QUARTER OPERATING INCOME OF $14.2 MILLION; EX-ITEMS, $15.7 MILLION, DOWN 14% SEQUENTIALLY, UP 4% YEAR-OVER-YEAR FOURTH QUARTER OPERATING MARGINS, EX-ITEMS, OF 12% FOURTH QUARTER GAAP EPS OF $0.15; EX-ITEMS, $0.22, DOWN 12% SEQUENTIALLY, UP 16% YEAR-OVER-YEAR FOURTH QUARTER FREE CASH FLOW OF $16.2 MILLION, UP OVER 50% SEQUENTIALLY DEBT LEVERAGE RATIO REDUCED TO 1.31, AND NET DEBT REDUCED BY $11.7 MILLION COMPANY REPURCHASED 264,982 SHARES OF COMMON STOCK, A VALUE OF $4.9 MILLION, DURING THE FOURTH QUARTER COMPANY ANNOUNCES Q1 2025 QUARTERLY DIVIDENDFULL YEAR REVENUE OF $523.8 MILLION, UP 3%FULL
CORE LABORATORIES ANNOUNCES TIMING OF FOURTH QUARTER 2024 EARNINGS RELEASE AND CONFERENCE CALL
HOUSTON, Jan. 3, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its fourth quarter 2024 conference call for investors and analysts at 7:30 a.m. CST / 8:30 a.m. EST on January 30, 2025. Larry Bruno, Chairman and CEO, Chris Hill, CFO, and Gwen Gresham, SVP Corporate Development and Investor Relations, will discuss financial and operational results. An earnings press release will be issued after market close on January 29, 2025 and may be accessed through the Company's website at www.corelab.com. To register for the listen-only webcast, log on to www.corelab.com at least fifteen minutes prior to the start of the call. For those not available to listen to the live webcast, a
SEC Form SC 13G/A filed by Core Laboratories Inc. (Amendment)
SC 13G/A - CORE LABORATORIES N V (0001000229) (Subject)
SEC Form SC 13G/A filed by Core Laboratories N.V. (Amendment)
SC 13G/A - CORE LABORATORIES N V (0001000229) (Subject)
SEC Form SC 13G/A filed by Core Laboratories N.V. (Amendment)
SC 13G/A - CORE LABORATORIES N V (0001000229) (Subject)